Skip to main content
Log in

Alirocumab/atorvastatin

Arthralgia, myalgia and lack of efficacy: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Matta A, et al. Ineffective subtilisin/kexin type 9 (Pcsk9) inhibitors monotherapy in dyslipidemia with low-density lipoprotein cholesterol (ldl-c) receptor abnormalities: A report of 2 cases. American Journal of Case Reports 21: 1-4, Jan 2020. Available from: URL: http://doi.org/10.12659/AJCR.923722

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alirocumab/atorvastatin. Reactions Weekly 1836, 40 (2021). https://doi.org/10.1007/s40278-021-87859-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-87859-0

Navigation